Muco Rhinathiol Volwassenen (Carbocisteine)

Carbocisteine, the active ingredient in Muco Rhinathiol Volwassenen, is a mucolytic presented as an oral formulation for oral use. It reduces the viscosity of respiratory tract secretions and is used to facilitate clearance of mucus in acute and chronic respiratory conditions.

GNH USA supplies Muco Rhinathiol Volwassenen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Carbocisteine acts on the respiratory mucus system and is indicated for conditions characterised by thick, productive secretions.

- Acute respiratory infections with productive cough: helps loosen and clear mucus, improving cough effectiveness. - Chronic bronchitis: reduces mucus thickness, aiding expectoration and relieving airway obstruction. - Chronic obstructive pulmonary disease (COPD): supports mucociliary clearance, decreasing cough frequency. - Mucus hypersecretion: diminishes mucus viscosity, facilitating easier removal.

Carbocisteine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools, usually transient. - Abdominal pain: discomfort in the stomach area. - Headache: mild to moderate head pain. - Rash: skin redness or itching.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Stevens‑Johnson syndrome: rare, serious skin disorder. - Hepatic enzyme elevation: potential liver function changes. - Blood dyscrasias: abnormal blood cell counts. - Bronchospasm: sudden narrowing of airways. - Severe gastrointestinal bleeding: uncommon but serious.

Use carbocisteine with awareness of patient‑specific factors and storage requirements.

- Renal function assessment: adjust use in patients with impaired kidney function. - Hepatic impairment caution: monitor liver status in those with liver disease. - Hypersensitivity avoidance: discontinue if allergic reactions develop. - Gastrointestinal monitoring: watch for persistent nausea or vomiting. - Pediatric supervision: only use under medical guidance for children. - Store at room temperature: keep in the original pack, protect from moisture.

Carbocisteine may interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - Antitussives containing codeine: may diminish mucolytic effectiveness. - Concurrent mucolytics: risk of excessive mucus thinning and gastrointestinal irritation.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): possible increase in bleeding tendency. - Macrolide antibiotics (e.g., erythromycin): may raise carbocisteine plasma concentrations. - Alcohol: can exacerbate gastrointestinal side effects.